Karen Pignet-Aiach
Chief Executive Officer chez LYSOGENE
Provenance du réseau au premier degré de Karen Pignet-Aiach
Entité | Type d'entité | Industrie | |
---|---|---|---|
23
| Public Company | Miscellaneous Commercial Services | 23 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Karen Pignet-Aiach via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
IPSEN | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
KPMG Peat Marwick SA
KPMG Peat Marwick SA Miscellaneous Commercial ServicesCommercial Services Part of DXC Technology Co., KPMG Peat Marwick SA is a French company that provides management consulting and information technology services. The private company is based in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Chief Operating Officer | |
Florida State University | College/University | Doctorate Degree | |
CELLECTIS S.A. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
London School of Economics & Political Science | College/University | Undergraduate Degree | |
Université Paris Dauphine-PSL | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Sogetrel SAS
Sogetrel SAS Specialty TelecommunicationsCommunications Sogetrel SAS engages in the design, deployment, and maintenance of network infrastructures and digital communication solutions. It offers turnkey solutions for the deployment, connection, commissioning of telecommunication networks, video surveillance, access control, intrusion detection, and advice and assistance in the implementation of smart city projects. The company was founded in 1985 and is headquartered in Issy-les-Moulineaux, France. | Specialty Telecommunications | Director/Board Member | |
Institut National Agronomique Paris-Grignon | College/University | Graduate Degree Undergraduate Degree | |
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young Audit SAS (France) is a French company that provides auditing and accounting services. The private company is based in Courbevoie, France. Founded in 1987. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
THERACLION | Medical Specialties | Director of Finance/CFO | |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Holding Incubatrice Internet | Investment Managers | Director/Board Member | |
Holding Incubatrice Telecom & Mobile | Investment Managers | Director/Board Member | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Université d'Aix-Marseille | College/University | Doctorate Degree | |
Sorbonne Université | College/University | Undergraduate Degree | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Messier Maris & Associés SCA provides financial consulting and investment advisory services. The company was founded by Jean-Marie Messier and Erik Maris in 2010 and is headquartered in Paris, France. | Investment Managers | Director/Board Member | |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Director/Board Member | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Eolas Biosciences Co., Ltd. | Corporate Officer/Principal | ||
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Chairman | |
Harvard Business School | College/University | Undergraduate Degree | |
20-20 Trustees Ltd.
20-20 Trustees Ltd. Investment ManagersFinance 20-20 Trustees Ltd. provides trustee services. It offers independent trusteeship, distressed situations, scheme changes, insolvency, and automatic enrolment services. The company was founded by Antony Miller and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member | |
Centre Hospitalier de Lannemezan
Centre Hospitalier de Lannemezan Hospital/Nursing ManagementHealth Services Centre Hospitalier de Lannemezan is a healthcare company located in Lannemezan Cedex, France. The French company's description mentions a call for applications for a night shift nurse position at the A1 Pole of the Cmp C Claudel. | Hospital/Nursing Management | Corporate Officer/Principal | |
Elektronika Telekomunikacja | Chairman | ||
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Aileens Pharma Srl is a holding company, which engages in the research and development of treatments for dermatological diseases. The company was founded by Sonia Longo Sormani in 2018 and is headquartered in Nova Milanese, Italy. | Miscellaneous Commercial Services | Chairman | |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman | |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | President | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
Eunetcom SA | Corporate Officer/Principal | ||
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Chairman | |
Cellectis Therapeutics | Chief Executive Officer | ||
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
France | 29 |
Etats-Unis | 11 |
Royaume-Uni | 4 |
Suisse | 4 |
Suède | 3 |
Sectorielle
Health Technology | 24 |
Consumer Services | 10 |
Commercial Services | 8 |
Finance | 5 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 108 |
Corporate Officer/Principal | 38 |
Chairman | 27 |
Independent Dir/Board Member | 24 |
Chief Tech/Sci/R&D Officer | 20 |
Relations les plus connectées
Insiders | |
---|---|
Stephan Christgau | 29 |
Chahra Khaoua Epouse Louafi | 26 |
Rafaèle Elisabeth Tordjman | 23 |
Mathieu Simon | 22 |
Michel Picot | 21 |
Olivier Danos | 15 |
David S. Schilansky | 11 |
Peter Lichtlen | 10 |
Annette Clancy | 10 |
Carole Deffez | 10 |
Philippe Pierre Goupit | 8 |
Céline Fantin | 7 |
Sean O'Bryan | 7 |
Sophie Olivier | 6 |
Ralph Laufer | 6 |
- Bourse
- Insiders
- Karen Pignet-Aiach
- Connexions Sociétés